Vir Biotechnology, Inc.
VIR
$10.80
-$0.39-3.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -251.68M | -442.72M | -437.99M | -499.65M | -550.23M |
| Total Depreciation and Amortization | 11.51M | 11.62M | 11.68M | 11.67M | 11.57M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 60.32M | 56.23M | 56.97M | 71.05M | 79.72M |
| Change in Net Operating Assets | -22.66M | -71.19M | -22.45M | -36.60M | 1.49M |
| Cash from Operations | -202.51M | -446.05M | -391.78M | -453.54M | -457.45M |
| Capital Expenditure | -1.09M | -3.59M | -4.83M | -6.48M | -8.93M |
| Sale of Property, Plant, and Equipment | -73.00K | -28.00K | 253.00K | 2.82M | 2.79M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -57.05M | 199.01M | 314.95M | 368.12M | 448.76M |
| Cash from Investing | -58.21M | 195.39M | 310.37M | 364.46M | 442.61M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 242.04M | 166.07M | 4.15M | 4.36M | 4.33M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.00K | -361.00K | -361.00K | -346.00K | -387.00K |
| Cash from Financing | 242.04M | 165.71M | 3.79M | 4.01M | 3.94M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.68M | -84.95M | -77.63M | -85.07M | -10.90M |